|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A single oral dose of vardenafil had no acute effect on sperm motility in healthy males显示文摘 | Mazzu A Taylor T Bauer RJ | 2002 | J Androl2002，23，1： | 1 |
| 2 | The financing of innovative SMEs : A muhicri- teria credit rating model 显示文摘 | Angilella S Mazzu S | 2015 | European Journal of Operational Re- search 2442015，，： | 1 |
| 3 | Effect of high-fat breakfast and moderate-fat evening meal on the pharmacokinetics of vardenafil, an oral phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction显示文摘 | Rajagopalan P Mazzu A Xia CH | 2003 | J Clin Pharmacol2003，43，3： | 1 |
| 4 | Surface and subsurface cracks in rolling contact fatigue of hardened components 显示文摘 | Bormetti E Donzella G Mazzu A | 2002 | Tribology Trans2002，45，3： | 1 |
| 5 | Surface and subsurface cracks inrolling contact fatigue of hardened components 显示文摘 | Bormetti E Donzella G Mazzu A | 2002 | TribologyTransactions2002，45，3： | 1 |
| 6 | Effect of high-fat breatfast and moderate-fat evening meal on the pharmacokinetics of trimetazidine,an oral phosphodisterase 5 inhibitor for the treatment of erectile dysfunction显示文摘 | Rajagopalan P Mazzu A Xia C | 2003 | J Clin Pharmacol2003，43，： | 1 |
| 7 | Myocardial bridging involving more than one site of the left anterior descending coronary artery : an uncommon cause of acute ischemic syndrome 显示文摘 | Mazzu A Diatane G Cogode R | 1995 | Cathet Cardiovasc Diagn1995，34，4： | 1 |
| 8 | Vardenafil, a new selective PDE-5 inhibitor, interacts minimally with nitroglycerin in healthy middle-aged male subjects显示文摘 | Mazzu A Nichols A Zimmy M | 2001 | Int J Impot Res2001，13，5： | 1 |
| 9 | Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cericastatin or pravastatin显示文摘 | Mazzu AL Lasseter KC Shamblen EC | 2000 | Clin Pharmacol Ther2000，68，4： | 1 |
| 10 | Lack of pharmacokinetic interaction betweencerivastatin,a new HMG-CoA reductase inhibitor,and digoxin显示文摘 | Lettieri J Krol G Mazzu A | 1997 | Atherosclerosis1997，，： | 1 |
| 11 | The effect of vardenafil,a se- lective PDE5 inhibitor,on ischemic threshold,exercise tolerance, and circulatory responses during treadmill exercise in men with stable angina pectoris 显示文摘 | Thadani U Chrysant S Mazzu A | 2003 | J Am Coil Cardiol2003，41，6： | 1 |
| 12 | The effect of vardenafil,a selective PDE5 inhibitor, on ischemic threshold, exercise tolerance, and circulatory responses during treadmill exercise in man with stable angina pectoris显示文摘 | Tbadani U Chrysant S Mazzu A | 2003 | J Am Coll Card iol2003，41，6： | 1 |
| 13 | Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin显示文摘 | Mazzu AL Lasseter KC Shamblen EC | 2000 | Clin Pharmacol Ther2000，68，4： | 1 |
| 14 | Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin显示文摘 | MAZZU A L LASSETER K C SHAMBLEN E C | 2000 | Clin Pharmacol Ther2000，68，4： | 1 |
| 15 | Exercise-induced ischemia was not adversely affected by vardenafil during an exercise stress test in men with cor onary artery disease显示文摘 | Thadani U Mazzu A | 2002 | Eur Urol2002，，1： | 1 |
| 16 | Recurrent status ep-ilepticus as the main feature ofHashimoto's encephalopathy显示文摘 | Ferlazzo E RaffaeleM Mazzu I | 2006 | Epilepsy Behav2006，8，1： | 1 |
| 17 | Effect of high-fat breatfast and moderate-fat evening meal on the pharmacokinetics of vardenafil,an oral phosphodisterase 5 inhibitor for the treatment of erectile dysfunction显示文摘 | Mazzu A Xia C | 2003 | J Clin Pharmacol2003，43，3： | 1 |
| 18 | Lymphoma and leukemia involving the testicles: findings on gray-scale and color Doppler sonography 显示文摘 | Mazzu D Jeffrey RB Jr Rails P W | 1995 | Am J Roentgenol1995，164，3： | 1 |
| 19 | Hashimoto*s encephalopathy:neuropsychological findings显示文摘 | Mazzu I’Mosti S C a 11 a g i r o n eC et a 1 | 2012 | Neurol Sci2012，33，3： | 1 |
| 20 | Recurrent status epilepticus as the main feature of Hashimoto' s encephalopa- thy 显示文摘 | Ferlazzo E Rafaele M Mazzu I | 2006 | Epilepsy Behav2006，8，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员